Deal With Arcellx Gives Gilead New Beachhead In Multiple Myeloma

Gilead and Arcellx announced a development and commercialization partnership for CART-ddBCMA • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business